|
||||||||||||||||||||||
|
||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
1 | AN ACT concerning public health.
| |||||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| |||||||||||||||||||||
3 | represented in the General Assembly:
| |||||||||||||||||||||
4 | Section 5. The Illinois Sexually Transmissible Disease | |||||||||||||||||||||
5 | Control Act is amended by changing Sections 3 and 6 as follows:
| |||||||||||||||||||||
6 | (410 ILCS 325/3) (from Ch. 111 1/2, par. 7403)
| |||||||||||||||||||||
7 | Sec. 3. Definitions. As used in this Act, unless the | |||||||||||||||||||||
8 | context clearly
requires otherwise:
| |||||||||||||||||||||
9 | (1) "Department" means the Department of Public Health.
| |||||||||||||||||||||
10 | (2) "Local health authority" means the full-time official | |||||||||||||||||||||
11 | health
department of board of health, as recognized by the | |||||||||||||||||||||
12 | Department, having
jurisdiction over a particular area.
| |||||||||||||||||||||
13 | (3) "Sexually transmissible disease" means a bacterial, | |||||||||||||||||||||
14 | viral, fungal or
parasitic disease, determined by rule of the | |||||||||||||||||||||
15 | Department to be sexually
transmissible, to be a threat to the | |||||||||||||||||||||
16 | public health and welfare, and to be a
disease for which a | |||||||||||||||||||||
17 | legitimate public interest will be served by providing
for | |||||||||||||||||||||
18 | regulation and treatment. In considering which diseases are to | |||||||||||||||||||||
19 | be
designated sexually transmissible diseases, the Department | |||||||||||||||||||||
20 | shall consider
such diseases as chancroid, gonorrhea, | |||||||||||||||||||||
21 | granuloma inguinale, lymphogranuloma
venereum, genital herpes | |||||||||||||||||||||
22 | simplex, chlamydia, nongonococcal urethritis
(NGU), pelvic | |||||||||||||||||||||
23 | inflammatory disease (PID)/Acute
Salpingitis, syphilis, |
| |||||||
| |||||||
1 | Acquired Immunodeficiency Syndrome (AIDS), and Human
| ||||||
2 | Immunodeficiency Virus (HIV) for designation, and shall | ||||||
3 | consider the
recommendations and classifications of the | ||||||
4 | Centers for Disease Control and
other nationally recognized | ||||||
5 | medical authorities. Not all diseases that are
sexually | ||||||
6 | transmissible need be designated for purposes of this Act.
| ||||||
7 | (4) "Health care professional" means a physician licensed | ||||||
8 | to practice medicine in all its branches, a physician assistant | ||||||
9 | who has been delegated the provision of sexually transmissible | ||||||
10 | disease therapy services or expedited partner therapy services | ||||||
11 | by his or her supervising physician, or an advanced practice | ||||||
12 | nurse who has a written collaborative agreement with a | ||||||
13 | collaborating physician that authorizes the provision of | ||||||
14 | sexually transmissible disease therapy services or expedited | ||||||
15 | partner therapy services, or an advanced practice nurse who | ||||||
16 | practices in a hospital or ambulatory surgical treatment center | ||||||
17 | and possesses appropriate clinical privileges in accordance | ||||||
18 | with the Nurse Practice Act. | ||||||
19 | (5) "Expedited partner therapy" means to prescribe, | ||||||
20 | dispense, furnish, or otherwise provide prescription | ||||||
21 | antibiotic drugs to the partner or partners of persons | ||||||
22 | clinically diagnosed as infected with a sexually transmissible | ||||||
23 | disease, without physical examination of the partner or | ||||||
24 | partners. | ||||||
25 | (Source: P.A. 85-1209.)
|
| |||||||
| |||||||
1 | (410 ILCS 325/6) (from Ch. 111 1/2, par. 7406)
| ||||||
2 | Sec. 6. Physical examination and treatment.
| ||||||
3 | (a) Subject to the provisions of subsection (c) of this | ||||||
4 | Section, the
Department and its authorized representatives may | ||||||
5 | examine or cause to be
examined persons reasonably believed to | ||||||
6 | be infected with or to have been
exposed to a sexually | ||||||
7 | transmissible disease.
| ||||||
8 | (b) Subject to the provisions of subsection (c) of this | ||||||
9 | Section, persons
with a sexually transmissible disease shall | ||||||
10 | report for complete treatment to a
physician licensed under the | ||||||
11 | provisions of the Medical Practice Act of
1987, or shall submit | ||||||
12 | to treatment at a facility provided by a local health
authority | ||||||
13 | or other public facility, as the Department shall require by | ||||||
14 | rule or
regulation until the disease is noncommunicable or the | ||||||
15 | Department determines
that the person does not present a real | ||||||
16 | and present danger to the public
health. This subsection (b) | ||||||
17 | shall not be construed to require the Department
or local | ||||||
18 | health authorities to pay for or provide such treatment.
| ||||||
19 | (c) No person shall be apprehended, examined or treated for | ||||||
20 | a sexually
transmissible disease against his will, under the | ||||||
21 | provisions of this Act,
except upon the presentation of a | ||||||
22 | warrant duly authorized by a court of
competent jurisdiction. | ||||||
23 | In requesting the issuance of such a warrant the
Department | ||||||
24 | shall show by a preponderance of evidence that the person is
| ||||||
25 | infectious and that a real and present danger to the public | ||||||
26 | health and
welfare exists unless such warrant is issued and |
| |||||||
| |||||||
1 | shall show that all other
reasonable means of obtaining | ||||||
2 | compliance have been exhausted and that no
other less | ||||||
3 | restrictive alternative is available. The court shall require
| ||||||
4 | any proceedings authorized by this subsection (c) to be | ||||||
5 | conducted in
camera. A record shall be made of such proceedings | ||||||
6 | but shall be sealed,
impounded and preserved in the records of | ||||||
7 | the court, to be made available
to the reviewing court in the | ||||||
8 | event of an appeal.
| ||||||
9 | (d) Any person who knowingly or maliciously disseminates | ||||||
10 | any false
information or report concerning the existence of any | ||||||
11 | sexually
transmissible disease under this Section is guilty of | ||||||
12 | a Class A misdemeanor.
| ||||||
13 | (e) Taking into account the recommendations of the U.S. | ||||||
14 | Centers for Disease Control and Prevention and other nationally | ||||||
15 | recognized medical authorities, the Department shall provide | ||||||
16 | information and technical assistance as appropriate to health | ||||||
17 | care professionals who provide expedited partner therapy | ||||||
18 | services for persons with sexually transmissible diseases. | ||||||
19 | (1) Notwithstanding any other provision of law, a | ||||||
20 | health care professional who makes a clinical diagnosis of | ||||||
21 | chlamydia or gonorrhea may prescribe, dispense, furnish, | ||||||
22 | or otherwise provide prescription antibiotic drugs to the | ||||||
23 | infected person's sexual partner or partners for the | ||||||
24 | treatment of the sexually transmissible disease without | ||||||
25 | physical examination of the partner or partners, if in the | ||||||
26 | judgment of the health care professional the partner is |
| |||||||
| |||||||
1 | unlikely or unable to present for comprehensive | ||||||
2 | healthcare, including evaluation, testing, and treatment | ||||||
3 | for sexually transmissible diseases. Expedited partner | ||||||
4 | therapy shall be limited to partners who may have been | ||||||
5 | exposed to a sexually transmissible disease within the | ||||||
6 | previous 60 days, if the patient is able to contact the | ||||||
7 | partner. | ||||||
8 | (2) Health care professionals who provide expedited | ||||||
9 | partner therapy shall comply with Sections 4 and 5 of the | ||||||
10 | Illinois Sexually Transmissible Disease Control Act. | ||||||
11 | (3) Health care professionals who provide expedited | ||||||
12 | partner therapy shall provide counseling for the patient | ||||||
13 | and written materials provided by the Department to be | ||||||
14 | given by the patient to the partner or partners that | ||||||
15 | include at a minimum the following: | ||||||
16 | (A) a warning that a woman who is pregnant or might | ||||||
17 | be pregnant must not take certain antibiotics and must | ||||||
18 | immediately contact a health care professional for an | ||||||
19 | examination, and a recommendation for such an | ||||||
20 | examination; | ||||||
21 | (B) information about the antibiotic and dosage | ||||||
22 | provided or prescribed; clear and explicit allergy and | ||||||
23 | side effect warnings, including a warning that a | ||||||
24 | partner who has a history of allergy to the antibiotic | ||||||
25 | or the pharmaceutical class of antibiotic must not take | ||||||
26 | the antibiotic and must be immediately examined by a |
| |||||||
| |||||||
1 | health care professional, and a recommendation for | ||||||
2 | such an examination; | ||||||
3 | (C) information about the treatment and prevention | ||||||
4 | of sexually transmissible diseases; | ||||||
5 | (D) the requirement of abstinence until a period of | ||||||
6 | time after treatment to prevent infecting others; | ||||||
7 | (E) notification of the importance of the partner | ||||||
8 | or partners of the patient to receive examination and | ||||||
9 | testing for HIV and other sexually transmissible | ||||||
10 | diseases, and available resources; | ||||||
11 | (F) notification of the risk to self, others, and | ||||||
12 | the public health if the sexually transmissible | ||||||
13 | disease is not completely and successfully treated; | ||||||
14 | (G) the responsibility of the partner or partners | ||||||
15 | to inform his or her sex partner or partners of the | ||||||
16 | risk of sexually transmissible disease and the | ||||||
17 | importance of prompt examination and treatment; and | ||||||
18 | (H) other information as deemed necessary by the | ||||||
19 | Department. | ||||||
20 | (4) The Department shall develop and disseminate in | ||||||
21 | electronic and other formats the following written | ||||||
22 | materials: | ||||||
23 | (A) informational materials for partners, as | ||||||
24 | required in item (3) of this subsection (e); | ||||||
25 | (B) informational materials for persons who are | ||||||
26 | repeatedly diagnosed with sexually transmissible |
| |||||||
| |||||||
1 | diseases; and | ||||||
2 | (C) guidance for health care professionals on the | ||||||
3 | safe and effective provision of expedited partner | ||||||
4 | therapy. | ||||||
5 | The Department may offer educational programs about | ||||||
6 | expedited partner therapy for health care professionals | ||||||
7 | and pharmacists licensed under the Pharmacy Practice Act. | ||||||
8 | (5) A health care professional prescribing, | ||||||
9 | dispensing, furnishing, or otherwise providing in good | ||||||
10 | faith without fee or compensation prescription antibiotics | ||||||
11 | to partners under this subsection (e) and providing | ||||||
12 | counseling and written materials as required by item (3) of | ||||||
13 | this subsection (e) shall not be subject to civil or | ||||||
14 | professional liability, except for willful and wanton | ||||||
15 | misconduct. A health care professional shall not be subject | ||||||
16 | to civil or professional liability for choosing not to | ||||||
17 | provide expedited partner therapy. | ||||||
18 | (Source: P.A. 90-14, eff. 7-1-97.)
|